Mirae Asset Global Investments Co., Ltd. Iovance Biotherapeutics, Inc. Transaction History

Mirae Asset Global Investments Co., Ltd.

$20 Billion
Q2 2024

A detailed history of Mirae Asset Global Investments Co., Ltd. transactions in Iovance Biotherapeutics, Inc. stock. As of the latest transaction made, Mirae Asset Global Investments Co., Ltd. holds 8,354 shares of IOVA stock, worth $84,960. This represents 0.0% of its overall portfolio holdings.

Number of Shares

8,354

Previous 88,278 90.54%

Holding current value

$84,960

Previous $1.31 Million 94.95%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 30, 2024	SELL	$7.78 - $14.19 $621,808 - $1.13 Million	-79,924 Reduced 90.54%	8,354 $66,000
Q1 2024 May 01, 2024	SELL	$7.59 - $17.47 $414,930 - $955,049	-54,668 Reduced 38.24%	88,278 $1.31 Million
Q4 2023 Jan 24, 2024	SELL	$3.3 - $8.89 $16,724 - $45,054	-5,068 Reduced 3.42%	142,946 $1.16 Million
Q3 2023 Oct 26, 2023	BUY	$4.44 - $8.79 $57,062 - $112,969	12,852 Added 9.51%	148,014 $673,000
Q2 2023 Aug 10, 2023	BUY	$5.36 - $9.06 $138,239 - $233,666	25,791 Added 23.58%	135,162 $951,000
Q1 2023 May 04, 2023	BUY	$5.53 - $8.22 $237,994 - $353,764	43,037 Added 64.88%	109,371 $668,000
Q4 2022 Feb 09, 2023	BUY	$5.62 - $10.0 $314 - $560	56 Added 0.08%	66,334 $423,000
Q3 2022 Nov 10, 2022	BUY	$9.53 - $13.11 $182,394 - $250,912	19,139 Added 40.6%	66,278 $635,000
Q2 2022 Jul 26, 2022	BUY	$6.38 - $18.33 $300,746 - $864,057	47,139 New	47,139 $520,000
Q1 2019 May 13, 2019	SELL	$8.41 - $11.26 $769,565 - $1.03 Million	-91,506 Closed	0 $0
Q4 2018 Feb 11, 2019	BUY	$7.51 - $11.93 $286,003 - $454,330	38,083 Added 71.29%	91,506 $810,000
Q3 2018 Nov 13, 2018	BUY	$11.25 - $17.7 $601,008 - $945,587	53,423 New	53,423 $601,000

Others Institutions Holding IOVA

# of Institutions

323

Shares Held

239M

Call Options Held

1.27M

Put Options Held

1.68M

View Full List

About IOVANCE BIOTHERAPEUTICS, INC.

Ticker IOVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 157,800,992
Market Cap $1.6B
Description
Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...

More about IOVA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mirae Asset Global Investments Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Mirae Asset Global Investments Co., Ltd. with notifications on news.

Account

Mirae Asset Global Investments Co., Ltd. Iovance Biotherapeutics, Inc. Transaction History